secwatch.observer — SEC 8-K summary
======================================

Issuer:     FOXO TECHNOLOGIES INC. (FOXO)
CIK:        0001812360
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001641172-25-026820
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Majority stockholder approves reverse stock split of FOXO common stock at ratio up to 1:500
--------------------------------------------------------------------------------

- Rennova Health (controlled by CEO) holds 60% voting rights, approved reverse split via written consent on Sept 2, 2025.
- Reverse split ratio from 1:10 to 1:500; Board will set exact ratio, must act by July 31, 2026.
- Company to file preliminary Schedule 14C; reverse split effective 20 days after mailing definitive statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812360/000164117225026820/0001641172-25-026820-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812360/000164117225026820/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026820

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer